Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access research articles of outstanding quality. Alzheimer's Research & Therapy publishes basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. Although the primary focus is Alzheimer's dementia, the scope will encompass translational research into other neurodegenerative diseases.
Antibodies-Online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 100 different manufacturers, we offer more than 224,000 antibodies. In addition the scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.
The Lancet Neurology is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to neurologists worldwide. It is the leading specialist neurology journal in the world with an impact factor of 18.13 (ISI Journal Citation Reports, 2010). The Lancet Neurology considers any original research contribution that advocates change in, or illuminates, neurological clinical practice. Topics include cerebrovascular disease, dementia/Alzheimer’s disease, epilepsy and seizures, genetics, headache and migraine, neurological infections, motor neuron disease/amyotrophic lateral sclerosis, movement disorders, multiple sclerosis, neuromuscular disorders, peripheral nerve disorders, paediatric neurology, sleep disorders, trauma and neurological tumours. For more information please visit www.thelancet.com/neurology